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Abstract
Macronutrient quality and composition are important determinants of energy balance and the gut microbiota. Here, we
investigated how changes to protein quality (casein versus whey protein isolate; WPI) and the protein to carbohydrate (P/C)
ratio within a high fat diet (HFD) impacts on these parameters. Mice were fed a low fat diet (10% kJ) or a high fat diet (HFD;
45% kJ) for 21 weeks with either casein (20% kJ, HFD) or WPI at 20%, 30% or 40% kJ. In comparison to casein, WPI at a
similar energy content normalised energy intake, increased lean mass and caused a trend towards a reduction in fat mass
(P= 0.08), but the protein challenge did not alter oxygen consumption or locomotor activity. WPI reduced HFD-induced
plasma leptin and liver triacylglycerol, and partially attenuated the reduction in adipose FASN mRNA in HFD-fed mice. High
throughput sequence-based analysis of faecal microbial populations revealed microbiota in the HFD-20% WPI group
clustering closely with HFD controls, although WPI specifically increased Lactobacillaceae/Lactobacillus and decreased
Clostridiaceae/Clostridium in HFD-fed mice. There was no effect of increasing the P/C ratio on energy intake, but the highest
ratio reduced HFD-induced weight gain, fat mass and plasma triacylglycerol, non-esterified fatty acids, glucose and leptin
levels, while it increased lean mass and oxygen consumption. Similar effects were observed on adipose mRNA expression,
where the highest ratio reduced HFD-associated expression of UCP-2, TNFa and CD68 and increased the diet-associated
expression of b3-AR, LPL, IR, IRS-1 and GLUT4. The P/C ratio also impacted on gut microbiota, with populations in the 30/
40% WPI groups clustering together and away from the 20% WPI group. Taken together, our data show that increasing the
P/C ratio has a dramatic effect on energy balance and the composition of gut microbiota, which is distinct from that caused
by changes to protein quality.
Citation: McAllan L, Skuse P, Cotter PD, Connor PO, Cryan JF, et al. (2014) Protein Quality and the Protein to Carbohydrate Ratio within a High Fat Diet Influences
Energy Balance and the Gut Microbiota In C57BL/6J Mice. PLoS ONE 9(2): e88904. doi:10.1371/journal.pone.0088904
Editor: Darcy Johannsen, Pennington Biomed Research Center, United States of America
Received July 23, 2013; Accepted January 13, 2014; Published February 10, 2014
Copyright:  2014 McAllan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: KN is supported by the Teagasc Vision Programme on Obesity, which also funded the work detailed in this manuscript. LM is supported by a Teagasc
PhD Walsh Fellowship. HMR is supported by SFI PI (11/PI/1119). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: Paul D. Cotter is a PLOS ONE Editorial Board member. The authors also declare that this does not alter their adherence to all the PLOS
ONE policies on sharing data and materials.
* E-mail: kanishka.nilaweera@teagasc.ie
Introduction
It is widely recognised that levels of obesity and related clinical
conditions such as diabetes, stroke, hyperlipidemia and cardiovas-
cular disease are increasing worldwide [1]. Importantly, the
development of obesity increases the set point at which the body
weight, more specifically body fat, is defended, thus making its
reversal difficult to achieve [2,3]. As such, there is an increased
research interest to develop effective treatments for this disease.
Dairy proteins belonging to the whey fraction (a by-product of
cheese manufacture) have been increasingly tested for their
potential anti-obesity effect, specifically for their ability to reduce
high fat diet (HFD)-associated body weight and fat mass gain [4–
6]. Shi et al., [7] showed that replacing 5%, 50% or 100% of the
dietary casein protein-derived energy content with a lactoperox-
idase and lactoferrin-enriched whey protein isolate (WPI) caused a
proportional suppression of body weight gain in HFD fed mice.
We have previously demonstrated that a WPI-related reduction in
body weight and fat mass gain in HFD fed mice was accompanied
by a normalisation of energy intake and complete or partial
reversal of energy balance-related gene expression in the adipose
tissue and the hypothalamus [8]. While these data suggest that
whey proteins have specific-effects on energy balance, such effects
appear be modified by the macronutrient composition in the diet
[9]. In the latter study, it was shown that increasing the lipid to
carbohydrate ratio within a whey protein-rich diet significantly
reduced energy intake and bodyweight gain in rats. Collectively,
these data suggest that protein quality and macronutrient
composition are important determinants of energy balance.
Interestingly, diet is also an important factor in determining the
composition of the gut microbiota [10,11] and specific gut
microbiota signatures are associated with obesity phenotypes in
animals and humans [12–14]. Notably, studies have shown specific
whey proteins to possess anti-microbial activity [15–17], and that
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the digestive process itself facilitates the formation of potent
antimicrobial whey-derived peptides, such as pepsin catalysed
lactoferrin to lactoferricin [18]. A study by Sprong et al., [19]
demonstrated that in comparison to casein, whey protein intake
increased levels of lactobacilli and bifidobacteria in a rat model of
colitis. However, in a more recent study, whey protein intake was
found to have no influence on gut microbiota composition in mice
fed a HFD for 7 or 13 weeks [20]. Several key unanswered
questions are; could whey proteins specifically influence the gut
microbiota composition associated with prolonged high fat
feeding, and would any changes relate to energy balance? Could
changes to protein to carbohydrate ratio within a HFD vary the
gut microbiota profile and energy balance in a different way to
changes to protein quality?
To assess WPI specific effects on above parameters, we
subjected male C57BL/6J mice to 21 weeks of either a low fat
diet (LFD) with 20% kJ casein or a HFD with 20% kJ casein or
WPI. In addition, using two additional HFD dietary groups on 30
or 40% kJ WPI, we evaluated the impact of increasing the protein
to carbohydrate (P/C) ratio within the HFD on parameters of
interest. Our data show that WPI has a specific effect on energy
balance and gut microbiota, while increasing the P/C ratio within
the HFD leads to dramatic alterations in energy balance, body
composition, metabolic health and the composition of the gut
microbiota.
Materials and Methods
Ethics Statement
All research involving mice was licensed under the Cruelty to
Animal Act 1876 and received ethical approval from the
University College Cork Animal Ethics Review Committee
(#2011/005).
Animals
Male 3–4 week old C57BL/6J mice (Harlan, Oxon, UK) were
group housed either 5 per cage (Study 1) or 4 per cage (Study 2) in
individually ventilated cages and acclimatised for four weeks in a
light (06:00–18:00), temperature (2161uC) and humidity (45–
65%) controlled environment with free access to water and a low
fat diet (LFD; 10% kJ fat and 20% kJ casein; #D12450, Research
diets; New Brunswick, NJ, USA).
Experimental protocol
Two studies were performed to assess how the WPI-derived
energy content within a HFD (study 1) or LFD (study 2) impacts
on energy balance-related parameters in mice over a 21 week
(study 1) or 7 week period (study 2).
Study 1: Following the acclimatisation period, weight-matched
dietary groups were maintained on the LFD or switched to either a
HFD (45% kJ fat and 20% kJ casein; #D12451) or a HFD with
WPI (Alacentm 895 NZMP, New Zealand) at an energy content of
20% kJ (HFD-20% WPI), 30% kJ (HFD-30% WPI) or 40% kJ
(HFD-40% WPI) (Table S1) (n = 10) for a total of 21 weeks. Body
weights were measured weekly. Energy intake in group housed
mice was measured by weighing the food hopper each week until
week 16. During weeks 17–20, energy intake and metabolic
activity in individual mice was measured using TSE Phenomaster
cages (TSE systems, Bad Homburg, Germany). Following this
analysis and prior to re-housing the mice in home cages, faecal
pellets were collected from individual mice for examination of
microbial composition via pyrosequencing and subsequent
bioinformatic analysis. At the end of the experimental period,
mice were fasted for 6 hours and the body composition was
measured using the Bruker minispec LF50H (Bruker optics,
Ettlingen, Germany). Mice were then anesthetised using ketamine
(65 mg/kg bodyweight) and xylazine (13 mg/kg bodyweight).
Blood was collected from anesthetised mice into vacutinater
EDTA tubes (BD, USA) and treated with Aprotinin
(500,000 KIU/L final concentration; Sigma, Ireland) and Dipro-
tin A (0.1 mM final concentration; Sigma, Ireland) to protect
plasma peptides from proteolytic degradation. Plasma was isolated
from blood by centrifugation at 2000 rpm at 4uC for 15 mins.
Mice were sacrificed by cervical dislocation, and tissues of interest
were dissected and snap frozen in liquid nitrogen (liver, adipose
and stomach) or on dry ice (brain). Plasma and tissue samples were
stored at 280uC until analysis.
Study 2: Weight matched mice were provided for 7 weeks with
either the LFD or a LFD with WPI replacing the casein protein
(LFD-WPI; 10% kJ fat and 20% kJ WPI) (n = 8). Body weights
were measured weekly. Energy intake and metabolic activity in
individual mice was measured during weeks 5 and 6 using the TSE
Phenomaster system. After the analysis, mice were re-housed, as
before, in the home cages and the experiment was terminated at
the end of week 7.
Analysis of metabolic parameters
The TSE Phenomaster cages comprised an open-circuit indirect
calorimetry system with gas sensing units to measure oxygen
consumption (ml/h/kg) (VO2) and CO2 production (ml/h/kg)
(VCO2). The cages also contained high precision sensor associat-
ed-feeding baskets to accurately measure food intake (g), with a
meal defined as intake over 0.01 g. A multi-dimensional infrared
beam system allowed the measurement of locomotor activity,
which was defined as the total number of infrared beam breaks in
the X and Y axis. Mice were singly housed in TSE Phenomaster
cages for a total of 3 days, with data collected during the final
24 hours, following a 2 day acclimatisation to the new cage
environment. The acclimatisation period was established based on
the data from our previous study [8]. Heat production (kcal/h/kg)
in individual mice was calculated using the Weir equation
(3.9416VO2 + 1.1066VCO2)[21]), and this was converted to
kJ/h/kg using 1kcal = 4.184 kJ. The respiratory exchange ratio
(RER) was calculated by VCO2/VO2. Energy intake was
calculated from food intake measurements using the energy
content of the diets supplied by the manufacturer.
Microbial DNA extraction, amplification and high
throughput DNA sequencing
Total metagenomic DNA was extracted from individual faecal
samples using QIamp DNA Stool Mini Kit (Qiagen, Hilden,
Germany), after an additional bead-beating step. Bacterial
composition was determined by sequencing of 16s rRNA
amplicons (V4-V5 region; 408nt long) generated by a separate
PCR reaction for each sample (in triplicate) using universal 16S
primers, where, the forward primer (59-AYTGGGYD-
TAAAGNG), with attached molecular identifier tags between
454 adapter sequence and target-specific primer sequence, and
reverse primer V5 (59-CCGTCAATTYYTTTRAGTTT) [22],
were used along with Biomix Red (Bioline, London UK). The
template DNA was amplified under the following PCR conditions
for a total of 35 cycles: 94uC for 2 minutes and 1 minute
respectively (initialization and denaturation), 56uC for 60 seconds
(annealing) and 72uC for 60 seconds (elongation), proceeded by a
final elongation stage of 2 minutes. Negative control reactions with
PCR grade water in place of template DNA were used to confirm
a lack of contamination. Amplicons were pooled and cleaned using
the AMPure XP purification system (Beckman and Coulter,
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Takeley, UK) and DNA concentration was determined using the
NANODROP 3300 Fluorospectrometer (Thermo Scientific, USA)
coupled with the Quant-itTM PicogreenH dsDNA Assay Kit
(Invitrogen, Paisley, UK). Equal volumes of each sample were then
pooled together and underwent a final cleaning and quantification
stage. Amplicons were sequenced in-house on a Roche GS FLX
Titanium platform.
Bioinformatics
Raw sequencing reads were ‘de-noised’ using traditional
techniques implemented in the Ribosomal Database Project
Pyrosequencing (RDP) Pipeline with ambiguous bases, non exact
primer matches and reads shorter than 150 bp being excluded.
Trimmed FASTA files were then BLASTed against a previously
published 16S-specific database using default parameters. The
resulting files were then parsed using the MEGAN software
package, which assigns reads to the National Centre for
Biotechnology Information (NCBI) taxonomies via the lowest
common ancestor algorithm. Results were filtered prior to tree
construction and summarization by the use of bit scores from
within MEGAN where a cut-off bit score of 86 was employed
[23,24]. The QIIME software suite was employed to achieve
clustering of sequence reads into operational taxonomic units
(OTUs) [25]. Chimeric OTUs were removed using the Chimer-
aSlayer program [26] and phylogenetic trees constructed using the
FastTreeMP tool [27]. Beta diversity values were calculated based
on Bray Curtis, weighted and unweighted UniFrac distances, and
the KING viewer was used to visualise resulting PCoA plots
[28,29]. Sequence reads were deposited in the European
Nucleotide Archive (EHA) under the accession number
PRJEB4636.
Plasma analysis
Colorimetric assays were used to measure plasma levels of
glucose (Calibochem, Darmstadt, Germany), triacylglycerol (TAG;
Wako Chemicals, Richmond, VI, USA) and non-esterified fatty
acids (NEFA; Abcam, Cambridge, UK). Commercially available
ELISA kits were used to analyse plasma levels of insulin, leptin
(Crystal Chem, Downers Grove, IL, USA), glucagon-like peptide 1
(GLP-1; Millipore, St. Charles, MO, USA) and corticosterone
(Enzo Life sciences, Farmingdale, NY, USA). The homeostasis
model assessment of insulin resistance (HOMA-IR) was deter-
mined using the formula: fasting plasma insulin (mU/ml)6 fasting
plasma glucose (mmol/L)/22.5 [30]. To measure plasma amino
acid levels, samples were first deproteinised by mixing with equal
volumes of 24% (w/v) tri-chloroacetic acid. The samples were
then allowed to stand for 10 minutes before been centrifuged at
144006g (Microcentaur, MSE, UK) for 10 minutes. Supernatants
were mixed with 0.2 M sodium citrate buffer, pH 2.2, and the
plasma concentration of amino acids were quantified using a Jeol
JLC-500/V amino acid analyser (Jeol Ltd., Garden city, UK)
fitted with a Jeol Na+ high performance cation exchange column.
Liver TAG analysis
Total lipids from liver samples (approx. 50 mg) were extracted
as described previously [8] using the Folch extraction method [31].
Briefly, total lipids were extracted using 2:1 (v/v) chloroform:
methanol solution, into which a 0.88% NaCl solution was added
before centrifugation at 2000 rpm and 4uC for 30 mins. Aliquots
of the organic phase were collected, dried and re-suspended in the
LabAssay TAG reagent (Wako Chemicals, Richmond, VI, USA)
to measure TAG levels using LabAssay TAG kit according to the
manufacturer’s protocol.
Real-Time PCR analysis
Total RNA was isolated from tissues using RNeasy mini (liver
and stomach) or RNeasy lipid mini (adipose and hypothalamus)
kits (Qiagen, Hilden, Germany) according to manufacturers’
instructions. RNA was treated with DNase (Qiagen, Hilden,
Germany) during RNA isolation to eliminate any possible genomic
DNA contamination. Reverse transcription of 1 mg of RNA was
performed using 2.5 ng/ml random hexamer primers (Bioline,
London, UK), 0.5 mM dNTP (Promega, Madison, VI, USA),
2 U/ml RNase inhibitor (Promega, Madison, VI, USA), and the
Superscript II first stand system (Invitrogen, Carlsbad, CA, USA)
according to manufactures’ instructions. Gene expression was
measured by the Roche Lightcycler 480 system (Rotkreuz,
Switzerland) via amplification of 1 ml complementary DNA using
the Lightcycler SYBR Green I Mastermix kit (Roche, Penzberg,
Germany) and 2.5 mM gene specific primers (Eurofins MWG
operon, Ebersberg, Germany) in a 10 ml total reaction volume.
Primer sequences used are listed in Table S2. PCR conditions
were; 10 mins at 95uC, followed by 50 cycles of 95uC for 10 s, 58–
65uC for 5 s and 72uC for 15 s. Authenticity of PCR products was
determined by melting curve analysis and by automated sequenc-
ing. Crossing point (Cp) of fluorescence signals were used to
calculate target gene expression by 22DDCp, following normalisa-
tion against housekeeping gene according to DDCp= DCp target
gene – DCp housekeeping gene. Housekeeping genes used were b-
actin (liver, stomach and hypothalamus), YWHAZ (liver and
hypothalamus), 18-S (adipose) and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (adipose and stomach). Relative gene
expression is shown compared to the LFD group.
Statistical analysis
Data are expressed as means 6 standard error of the mean
(SEM). Differences between experimental dietary groups were
analysed by one-way or two-way ANOVA followed by pairwise
comparisons using tukey or bonferroni post hoc tests, respectively.
Body weight trajectories were analysed by two-way repeated
measures ANOVA with bonferroni post hoc tests. Non-parametric
data was compared by Kruskal-Wallis ANOVA followed by Dunn’s
pairwise comparisons. Significance levels were set at P#0.05, and
statistical analysis was performed using Graphpad prism (ver. 5.04;
San Diego, CA, USA) and Minitab (ver.15; State College, PA,
USA).
Results
WPI inclusion or increasing the P/C ratio within a HFD
alters body composition and plasma amino acids
Fig. 1A–B demonstrates that body weight gain of HFD-
20%WPI fed mice was similar to HFD controls. However, intake
of WPI was seen to have a specific effect on body composition,
with HFD-20% WPI fed mice having an increased lean mass (%)
(P,0.05), and a trend towards a reduction in fat mass (%)
(P= 0.08) compared to the HFD control group. Increasing the
WPI derived energy content in the HFD to 40% and proportion-
ally reducing the carbohydrate energy content led to a significant
reduction in body weight gain compared to all other HFD-WPI
groups (P,0.001), with observed values similar to that seen for the
LFD group. This was accompanied by significantly reduced body
fat mass and increased lean mass levels in the HFD-40% WPI fed
mice compared to HFD control and other WPI diets groups (P,
0.001), while the body composition of HFD-30% WPI group did
not differ from that of the HFD-20% WPI group (Fig. 1C).
Comparison of the plasma amino acid profiles including those
that could influence lean and fat mass, revealed an impact of WPI
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and the P/C ratio (Table 1). WPI specific effects were observed on
glutamic acid, aspartic acid and glycine, which either decreased
(glutamic acid and aspartic acid) or increased (glycine) compared
to HFD fed mice (P,0.05) (Table 1). Changes in macronutrient
ratio in HFD-40%WPI, decreased plasma histidine, phenylala-
nine, serine and threonine levels compared to the lowest P/C ratio
(20% WPI) (P,0.01) (Table 1).
WPI-enriched HFD normalised energy intake, while
increasing the P/C ratio accentuated metabolism
The cumulative energy intake (MJ) for the dietary groups
(2 cages/group, all with n= 5 mice), measured over the first 16
weeks did not differ between LFD, HFD and HFD-20% WPI
groups (24.7362.70 vs. 27.6961.54 vs. 29.4060.31, respectively).
In contrast, data gathered by individually housing the mice in TSE
Phenomaster cages in weeks 17–20 demonstrated that the energy
intake of the HFD-WPI groups was greater than that of the HFD
control group during both the light and dark phases (P,0.05),
while being similar to that of the LFD group (Fig. 2A). Increasing
the P/C ratio had no significant effect on cumulative energy intake
(MJ) in HFD fed mice up to week 16 (20%WPI, 29.4060.31 vs.
30%WPI, 30.0160.62 vs. 40%WPI, 26.7160.15). Energy intake
measurements from TSE Phenomaster cages corroborated this
data (Fig 2A). There was also no significant effect on meal number
or meal size of altering the P/C ratio (i.e. between WPI groups;
Fig 2B–C).
The HFD-20% WPI diet had no impact on VO2, heat
production, locomotor activity or respiratory exchange ratio
(RER) when compared to HFD fed mice (Fig. 3A–D). Increasing
the P/C ratio was found to impact on energy expenditure with
HFD-40% WPI fed mice having significantly increased levels of
dark phase VO2 compared to HFD-20 and 30% WPI fed mice
(P,0.001) (Fig 3A). A similar change in heat production was
observed between the groups, albeit data was only significant
between HFD-40% and HFD-30%WPI groups (P,0.05) (Fig 3B).
There was no effect of WPI or P/C ratio on locomotor activity
(Fig 3C). RER values of all HFD groups were lower than the LFD
group in both the light and dark phases, consistent with increased
fat metabolism (P,0.001) (Fig 3D).
Investigation of the above parameters in mice fed a LFD with
WPI or casein for 7 weeks (study 2) revealed that WPI does not
influence body weight, energy intake, VO2, locomotor activity or
RER in a low fat background (Figure S1A–D).
Increasing the protein to carbohydrate ratio attenuated
adverse metabolic impact of HFD
Specific effects of WPI and the P/C ratio were observed on lipid
metabolism-related gene expression and on tissue lipid deposition.
Firstly, the decrease in epididymal adipose tissue fatty acid
synthase (FASN) mRNA expression with HFD feeding, was
somewhat attenuated by WPI challenge (P,0.05), with no added
benefit of increasing the P/C ratio on expression of this gene
(Fig 4A). Notably, the epididymal mRNA expression of a number
of other genes were altered by the P/C ratio, specifically, fatty acid
transporter 1 (FATP1), beta-3 adrenergic receptor (b3-AR),
peroxisome proliferator-activated receptor gamma (PPARc),
uncoupling protein 2 (UCP-2) and lipoprotein lipase (LPL) (P#
0.05) (Fig 4). In the liver, WPI specifically reduced TAG levels
(Table 2) and the mRNA expression of fatty acid binding protein 1
(FABP1) compared to HFD fed mice (Table 3). The highest P/C
ratio (40% WPI) significantly decreased mRNA levels of cluster of
differentiation 36 (CD36) and PPARc (P,0.05) (Table 3),
dramatically reduced liver TAG levels compared to 20/30%
WPI fed mice (Table 2), and normalised the elevated plasma levels
of TAG and NEFA observed with HFD feeding (P#0.05)
(Table 2). Finally, the mRNA level of lipid metabolism-related
Figure 1. Impact of whey protein isolate and protein to
carbohydrate ratio on body weight and composition. (A) shows
the body weight trajectories of mice during 21 weeks of dietary
treatment with a 10% kJ low fat diet (LFD), 45% kJ high fat diet (HFD) or
a HFD with 20, 30 or 40% kJ whey protein isolate (WPI). Body weight
gain (B) and body composition (C) of mice after 21 weeks on
experimental diets are also shown. Data represent mean values 6
S.E.M. (n = 10 per group). Groups that do not share a common letter are
significantly different at P,0.05.
doi:10.1371/journal.pone.0088904.g001
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carnitine palmitoyltransferase 1a-c (CPT1a-c), fatty acid transport
protein 5 (FATP5) and PPARa, in tissues of interest, was not
influenced by the dietary challenges (Tables 3–4).
Increasing the P/C ratio reduced plasma glucose levels,
particularly in the 40% WPI group (P,0.05) (Table 2). In parallel
HOMA-IR values were also reduced (P,0.05), but the change in
plasma insulin concentration did not reach statistical significance
(Table 2). At a cellular level, the highest P/C ratio normalised the
HFD-induced reduction in adipose expression of insulin receptor
(IR) and insulin receptor substrate 1 (IRS-1), and partially
prevented the HFD-induced reduction in glucose transporter 4
(GLUT4) (Fig. 4B) (P,0.001). In the hypothalamus, WPI
specifically increased IR mRNA expression (P,0.05), as did P/
C ratio, with the highest P/C ratio having the greatest impact
(Table 4). Epididymal adipose tissue mRNA expression of
inflammatory markers, namely tumour necrosis factor (TNF)-a
and cluster of differentiation (CD) 68 only responded to the highest
P/C ratio, which significantly reduced the expression of both in a
HF background (Fig. 4B) (P,0.001). In the hypothalamus, whilst
TNFa mRNA was elevated by HFD feeding, neither WPI nor the
P/C ratio influenced its levels, although there was a trend towards
a decrease for the highest P/C ratio (40% WPI) (Table 4). None of
the dietary challenges influenced hepatic glucose transporter 2
(GLUT2), IRS-1 and TNF-a mRNA expression (Table 3) or
hypothalamic IRS-1 mRNA expression (Table 4).
The increased plasma leptin concentration in response to the
HFD was significantly blunted by WPI intake with dramatic
reductions seen at the highest P/C ratio (P,0.001) (Table 2). Yet,
the hypothalamic expression of genes known to be responsive to
plasma leptin levels were unaffected, specifically mRNA levels of
leptin receptor (ObR), pro-opiomelanocortin (POMC), neuropep-
tide Y (NPY) and growth hormone secretagogue receptor (GHS-R)
(Table 4). In addition, gastric mRNA expression for the orexigenic
hormone ghrelin was not found to significantly differ between all
dietary treatment groups (1.0060.37, LFD vs. 1.1160.40, HFD
vs. 0.7360.35, 20%-WPI vs. 0.2960.28, 30%-WPI vs. 1.0760.45,
40%-WPI). Plasma corticosterone levels were also elevated with
HF feeding, but were not influenced by protein source (WPI or
casein) or P/C ratio (Table 2). Similarly, there was no effect of
WPI on the HFD-associated suppression of adipose 11b-hydroxy-
steroid dehydrogenase type 1 (11bHSD1) (Fig 4B), or the HFD-
induced increase in glucocorticoid receptor (GCCR) in the
hypothalamus (Table 4).
WPI inclusion or increasing the P/C ratio within a HFD
altered the composition of gut microbiota
A total of 251,395 V4–V5 16s rRNA sequence reads were
generated which corresponded to an average of 50,279 reads per
diet group or 5,130 reads per animal. a-diversity values were
calculated for biodiversity (Shannon index), species richness
(Chao1) and the number of species relative to the abundance in
the sample (Simpson diversity index). When a-diversity values
were compared by diet group, the only difference observed was a
significantly higher microbial richness (Chao1) within the HFD
microbiota compared to the HFD-30% WPI (P= 0.028). Principal
coordinate analysis (based on unweighted UniFrac distances)
(Fig. 5) of the sequence data highlighted a clustering of the LFD,
HFD and HFD-20% WPI group microbial populations, while
HFD-30% and 40% WPI groups clustered in close proximity to
each other and distinctly from the LFD, HFD and HFD-20%WPI
group clusters. Indeed, the LFD diet with casein as a protein
source clustered most closely with the HFD containing the casein
protein.
Phylogenetic analysis revealed several significant microbial
population shifts between the HFD control and WPI groups
(Table 5). At the family level, all WPI diet groups had significantly
increased proportions of Lactobacillaceae and significantly decreased
proportions of Clostridiaceae compared to the HFD control group.
Bifidobacteriaceae populations were increased in both the HFD-20%
Table 1. Plasma amino acid levels (mmol/L) in mice fed a 45%kJ high fat diet (HFD) or HFD with 20%, 30% or 40% kJ whey protein
isolate (WPI) for 21 weeks1.
HFD 20% WPI 30% WPI 40% WPI P value
Alanine 170.9168.82a 163.83611.59ab 137.4469.72ab 127.1568.46b ,.05
Arginine 41.7464.82 38.4167.16 56.3967.60 39.0864.34 NS
Aspartic acid 7.4761.25a 3.6360.51b 3.4960.51b 4.8561.02ab ,.05
Cyteine 11.9561.34 8.8761.37 8.9361.33 7.8661.72 NS
Glutamic acid 90.7663.42a 74.7461.89b 75.2561.86b 71.2562.69b ,.001
Glycine 106.2264.28a 131.4363.57b 116.4564.52ab 131.9262.69b ,.001
Histidine 75.4362.12a 74.9362.98a 68.2163.35ab 64.2162.51b ,.05
Isoleucine 213.8168.87 207.8769.09 195.2765.74 186.78610.17 NS
Leucine 91.8669.66 81.3666.65 66.9366.69 69.71610.21 NS
Lysine 113.8165.88 108.1868.30 102.5768.39 88.2964.07 NS
Methionine 23.9461.77 23.6560.75 21.0560.97 20.4061.08 NS
Phenylalanine 46.9261.70a 41.1361.13ab 38.2361.52bc 33.3062.35c ,.001
Proline 118.26610.14 127.6369.63 106.04611.02 104.39611.93 NS
Serine 68.1865.69ab 74.9862.29a 62.4262.57ab 55.7362.12b ,.01
Threonine 92.7162.93a 87.6362.49a 78.2962.95ab 69.2863.96b ,.01
Tyrosine 40.2962.47a 36.3761.12ab 33.7661.54ab 29.6362.77b ,.01
Valine 154.5168.65a 130.5965.99ab 118.4066.69b 113.1669.49b ,.01
1Data are means 6 SEM (n = 7–10). In each row values without a common letter significantly differ, P,0.05;NS, non-significant.
doi:10.1371/journal.pone.0088904.t001
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WPI and HFD-30% WPI diet groups compared to the HFD
control, while in contrast they were significantly lower in the
HFD-40% WPI group compared to the HFD control. The
aforementioned patterns were also observed with respect to the
corresponding genera (Lactobacillus, Clostridium and Bifidobacterium
respectively) (Table 5). Also at genus level, proportions of Rikenella
Figure 2. Impact of whey protein isolate and protein to
carbohydrate ratio on energy intake. Energy intake (A) and
feeding behaviour (meal size & meal number) (B–C) was measured
using TSE Phenomaster cages at 17–20 weeks for mice on either a 10%
kJ low fat diet (LFD), 45% kJ high fat diet (HFD) or a HFD with 20, 30 or
40% kJ whey protein isolate (WPI). Experimental data collected from
individual mice at 9 minute intervals over a 24 hour period are shown
as mean values6 SEM (n = 8–10 per group) for light and dark phases. In
light and dark phase, groups that do not share a common letter are
significantly different at P,0.05.
doi:10.1371/journal.pone.0088904.g002
Figure 3. Impact of whey protein isolate and protein to
carbohydrate ratio on metabolic activity. Metabolic activity was
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were significantly higher in the HFD-40% WPI group compared
to HFD-20/30% WPI groups, while proportions of Peptostrepto-
coccus were significantly higher in the HFD-40% WPI group than
in any other diet group (Table 5). Specific comparison of the
microbiota of the HFD-20% WPI and HFD control was deemed
particularly important given that the changes occurring here
reflected changes resulting specifically from the presence of whey
protein, rather than casein, in the diet, and not simply a change in
the P/C ratio in the diet. In addition to the changes in the
Lactobacillus, Clostridium and Bifidobacterium populations (and associ-
ated families) referred to above, it was also noted that proportions
of Desulfovibrio and Mucisprillum (genus) were increased in the HFD-
20% WPI relative to HFD control animals.
Discussion
The key findings of this study are that WPI has a specific effect
on HFD-induced energy intake, metabolic health and gut
microbiota composition. Additionally, with the exception of
energy intake, increasing the P/C ratio, by increasing WPI
dietary content, was seen to dramatically alter the above
parameters.
Energy intake
Cumulative energy intake measured up to week 16 did not
significantly differ between LFD and HFD fed mice. While this is
consistent with data reported elsewhere [20], HF feeding has also
been shown to increase or decrease energy intake in rodents
[32,33]. Differences between data reported may relate to variances
in diet composition including fat source/composition, or it may be
measured using TSE Phenomaster cages at 17–20 weeks for mice on
either a 10% kJ low fat diet (LFD), 45% kJ high fat diet (HFD) or a HFD
with 20, 30 or 40% kJ whey protein isolate (WPI). Experimental data for
(A) oxygen consumption (VO2), (B) heat production, (C) locomotor
activity and (D) respiratory exchange ratio (RER), collected from
individual mice at 9 minute intervals over a 24 hour period, are shown
as mean values6 SEM (n = 8–10 per group) for light and dark phases. In
light and dark phase, groups that do not share a common letter are
significantly different at P,0.05.
doi:10.1371/journal.pone.0088904.g003
Figure 4. Impact of whey protein isolate and protein to carbohydrate ratio on adipose cellular activity. Epididymal adipose tissue gene
expression was investigated in mice after 21 weeks on a 10% kJ low fat diet (LFD), 45% kJ high fat diet (HFD), or HFD with 20, 30 or 40% kJ whey
protein isolate (WPI). Relative mRNA expression is shown for (A) fatty acid synthase (FASN), fatty acid transporter 1 (FATP1), cluster of differentiation
36 (CD36), beta-3 adrenergenic receptor (b3-AR), uncoupling protein 2 (UCP-2), lipoprotein lipase (LPL) and carnitine palmitolytransferase 1b (CPT1b),
and (B) for peroxisome proliferator activated receptor gamma (PPARc), insulin receptor (IR), insulin receptor substrate 1 (IRS-1), glucose transporter 4
(GLUT4), 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1), tumour necrosis factor alpha (TNF-a) and cluster of differentiation 68 (CD68). Data
represent mean values6 SEM (n= 9–10 per group). Gene expression is shown relative to the LFD control group set at 1.00. Groups that do not share
a common letter are significantly different at P,0.05.
doi:10.1371/journal.pone.0088904.g004
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due to differences in the palatability of the LFD used as the control
[33,34].
In this study, there was a discrepancy in energy intake in HFD
fed mice depending on the housing environment (single or group
housed). In contrast to the group house environment up to week
16, HFD fed mice when individually housed in metabolic cages
during weeks 17–20 showed a hypophagic response compared to
LFD fed mice. It is possible that these differences may be related to
the accuracy of the method used to measure food intake in group
versus single housed mice, although if this was an error due to
methodology, then it would likely to have influenced all dietary
groups equally and not just the HFD group. Alternatively, the
different behavioural responses could be result of social isolation,
which has been shown to decrease energy intake and elevate
plasma corticosterone levels [35,36]. However, socially isolated
mice adapt to the new environment and consume similar amounts
of food as pre-adapted singularly housed mice 6 hr post-novelty
stress, but interestingly 24hr later, their food intake reduces
significantly once again in the new environment, suggesting that
stress of social isolation could extend up to 24 h [36]. We showed
that group housed mice on a LFD when placed in isolation adapt
to the new environment and continue to consume similar amounts
of food by day 2 and 3 in the new location [8] and consequently
used the day 3 time point to measure energy intake in this study.
Rodents on a HFD have been shown to display increased anxiety
[37], and have an over-active hypothalamic-pituitary-adrenal axis
[38,39] resulting in elevated plasma corticosterone levels, as
demonstrated here. This could explain why HFD fed mice are
more susceptible to stress stimuli with more pronounced reduc-
tions in energy intake compared LFD fed counterparts subjected
to the same stress levels [40–42]. Consequently, in a HFD
background, it’s possible that social isolation-induced stress
responses could have had a greater impact on energy intake with
effects lasting up to the 3 day housing period as used in this study.
Given the finding that whey proteins such as lactoferrin and a-
lactalbumin and native whey protein itself reduce stress [43–47], it
is possible that replacing the casein protein with an equivalent
WPI content caused normalisation of energy intake in HFD-fed
mice by affecting a specific feeding behaviour related mecha-
nism(s), with increasing the WPI protein-derived bioactives having
no further effect. This WPI effect on energy intake appeared be
specific to the HFD-induced neuroendocrine state because mice
on the LFD with WPI showed similar energy intake to casein diet-
fed controls. Since neither WPI nor increasing the P/C ratio
influenced plasma corticosterone levels, adipose expression of 11b-
HSD1 or hypothalamic expression of GCCR in HFD fed mice, it
is possible that WPI may have affected other central mechanisms
mediating stress responses not investigated in this study [48–50]
either independently or in combination with key mechanisms
regulating energy balance. Given that leptin decreases meal size
and number [51–53], and WPI reduced the HFD-induced
increase in plasma leptin levels, it’s possible that WPI-derived
bioactives could have specifically influenced circadian rhythm of
leptin production and/or action within the neuroendocrine state
of HFD-fed mice in a socially isolated environment. Additionally,
the reduction in plasma amino acids associated with WPI intake
(see below), could also have acted as a possible central trigger to
increase energy intake in WPI groups compared to HFD control in
the single house environment.
HFD feeding has been shown to cause a gain of weight in rats
up to the duration of a test period lasting 76 weeks, with animal’s
body weight gain responding to changes to the dietary fat content
introduced at various time points [54]. Lin et al., [32] demon-
strated that mice on a HFD for 19 weeks are responsive to
intracerebroventricular administration of leptin. These data
suggest that energy balance related mechanisms are able to
respond to energetic challenges even after prolonged high fat
intake. High protein intake within a HFD suppresses energy intake
[55,56] albeit not consistently [4,57], and in our study, the P/C
ratio did not alter energy intake in either housing environment.
This could be a result of the quantity or composition of the
macronutrient used in the test diets. Indeed, data from human
trials showed that increasing protein dietary content (10/15% to
30%) only decreased energy intake when the carbohydrate
content was kept constant [58,59]. This further highlights the
importance of designing appropriate experimental diets with
the correct macronutrient composition for uncovering the
energy balance related impact of the dietary component under
investigation.
Metabolic health
Replacement of the casein protein with an equivalent energy
content of WPI (i.e. 20%) did not specifically alter metabolic
activity, heat production or locomotor activity in HFD or LFD fed
mice. In contrast, Acheson et al., [60] showed that whey has a
greater thermic effect than casein or soy in humans. These
Table 2. Tissue lipid parameters and plasma levels of hormones and metabolites in mice fed a 10%kJ low fat diet (LFD), 45%kJ
high fat diet (HFD) or HFD with 20%, 30% or 40% kJ whey protein isolate (WPI) for 21 weeks1.
LFD HFD 20% WPI 30% WPI 40%WPI P value
Liver TAG (mg/g tissue) 71.4769.17a 139.0366.92b 104.9465.88c 107.2168.83c 70.8267.64a ,.001
Leptin (ng/ml) 4.4160.75a 84.6963.17b 53.7865.67c 51.1264.69c 15.0164.07a ,.001
TAG (mg/dl) 39.8562.91a 56.9066.31b 45.1564.32ab 52.3663.91ab 40.1963.96a ,.05
NEFA (mmol/L) 0.3760.09a 0.6760.07b 0.6460.05b 0.6360.06b 0.3660.05a ,.01
Corticosterone (ng/ml) 150.0621.7a 319.0648.6b 286.8631.9ab 334.1636.7b 277.1635.5ab ,.01
GLP-1 (pM) 25.0362.47 33.1562.83 28.0762.3 27.8861.98 24.0362.25 NS
Glucose (mmol/L) 9.1461.24a 15.6860.83b 13.9260.95b 14.0861.05b 9.2560.77a ,.001
Insulin (ng/ml) 0.2960.05 0.5560.08 0.4060.10 0.3760.04 0.3160.06 NS
HOMA-IR 2.4860.67a 9.7961.07b 6.8162.58ab 6.2060.95ab 3.0460.64a ,.01
1Data are means6 SEM (n = 5–10). In each row results without a common letter significantly differ, P#0.05 NS, non-significant. TAG, triacylglycerol. NEFA, non-esterified
fatty acids. GLP-1, glucagon-like peptide 1. HOMA-IR, homeostasis model assessment of insulin resistance.
doi:10.1371/journal.pone.0088904.t002
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differences in data may be related to the fact that the latter study
only investigated an acute post-prandial response to a defined test
meal, or it may relate to how different species (humans versus
mice) digest and metabolise dietary proteins. Shetzer et al, found
that mice consuming a HFD and WPI-supplemented drinking
water have enhanced oxygen consumption compared to mice
drinking unsupplemented water [4]. In this instance, the increased
metabolic activity may have arisen due to the increased protein
intake (proteins from diet and from WPI supplemented water). In
fact, this corroborates with the data presented here, which show
that increasing the P/C ratio resulted in increased energy
expenditure (VO2 and heat production) and dark phase locomo-
tors activity, resulting presumably from the increased catabolism of
ingested dietary protein, coupled with thermic effects of WPI
compared to casein [60] and/or due to increased deposition of
lean mass with WPI content [61–63]. Interestingly, Zhang et al.
[64] showed that HFD fed mice on leucine-supplemented drinking
water have reduced fasting plasma levels of aspartic acid, glutamic
acid, and phenylalanine, as well as increased VO2 and reduced
adiposity compared to HFD controls. Given the influence of
leucine on WPI-induced muscle hypertrophy [65,66] and its
unique ability to regulate the translation of protein synthesis [67],
it is possible that the elevated leucine content found normally in
the WPI diets may have enhanced muscle protein synthesis by
directing other amino acids towards protein synthesis and/or
catabolism [68,69], with the required energy been derived possibly
from fat catabolism [70]. Consistent with the latter suggestion,
we found an increased lean mass and a trend towards a reduc-
tion in fat mass with decreased plasma levels of several amino
acids, but not leucine, when the casein protein in a HFD
was replaced with WPI or when the P/C ratio in the HFD was
increased.
WPI intake appeared to cause a trend towards a reduction in fat
mass, and in the liver this manifested as a WPI specific reduction
Table 3. Relative hepatic gene expression in mice fed a 10%kJ low fat diet (LFD), 45%kJ high fat diet (HFD) or HFD with 20%, 30%
or 40% kJ whey protein isolate (WPI) for 21 weeks1.
LFD HFD 20% WPI 30% WPI 40% WPI P value
CD36 1.0060.20a 2.8560.34b 2.9860.45b 2.1760.25ab 1.5060.25a ,.05
PPARc 1.0060.12a 3.0060.57b 2.3060.49b 1.8860.46b 0.8560.13a ,.001
FABP1 1.0060.09ab 1.2760.10b 0.8660.06ac 1.2760.17bc 0.7160.09a ,.001
IRS-1 1.0060.15a 0.5860.04b 0.6960.05ab 0.6860.06ab 0.7960.06ab ,.01
CPT1a 1.0060.08 0.8560.08 0.9760.06 0.9060.13 0.8660.10 NS
GLUT2 1.0060.09 0.7660.04 1.0260.08 0.9760.09 0.8960.05 NS
FATP5 1.0060.21 0.8960.07 0.8860.07 1.1660.07 1.2460.12 NS
FASN 1.0060.36 0.4660.14 0.5460.19 0.4060.06 0.3260.04 NS
PPARa 1.0060.04 1.1360.05 1.2160.05 1.1760.10 1.2860.11 NS
TNFa 1.0060.26 0.8460.15 1.1260.18 0.8060.09 0.7160.10 NS
1Data are means 6 SEM (n = 7–10). In each row results without a common letter significantly differ, P,0.05; NS, non-significant. Gene expression shown relative to the
LFD control group set at 1.00.CD36, cluster of differentiation 36; PPARc, peroxisome proliferator activated receptor gamma; FABP1, Fatty acid binding protein 1; IRS-1,
Insulin receptor substrate 1; CPT1a, carnitine palmitoyltransferase 1a; GLUT2, Glucose transporter 2; FATP5, Fatty acid transporter 5; FASN, Fatty acid synthase; TNF-a,
Tumour necrosis factor alpha.
doi:10.1371/journal.pone.0088904.t003
Table 4. Relative hypothalamic gene expression in mice fed a 10%kJ low fat diet (LFD), 45%kJ high fat diet (HFD) or HFD with 20%,
30% or 40% kJ whey protein isolate (WPI) for 21 weeks1.
LFD HFD 20% WPI 30% WPI 40% WPI P value
IR 1.0060.03ab 0.9760.07a 1.2260.04bc 1.3760.04cd 1.5560.08d ,.05
GCCR 1.0060.09a 1.4060.10b 1.3460.07ab 1.3060.08ab 1.4260.09b ,.05
TNFa 1.0060.05a 1.7660.09b 1.5760.13b 1.4760.14ab 1.4060.25ab ,.01
POMC 1.0060.08 0.9960.06 1.0160.06 0.9860.06 1.0060.08 NS
NPY 1.0060.04 1.0260.09 0.9060.06 0.8860.05 0.9260.08 NS
ObR 1.0060.11 0.9260.05 0.9960.05 1.0760.07 0.9560.05 NS
GHS-R 1.0060.07 0.9860.06 0.9860.08 1.0260.11 1.0460.09 NS
PPARc 1.0060.36 1.0760.04 0.9560.05 0.9960.05 0.9860.07 NS
CPT1c 1.0060.09 0.9260.04 0.9160.01 0.9760.06 0.8660.04 NS
IRS-1 1.0060.04 0.9960.04 0.9760.02 1.0660.08 1.0060.06 NS
1Data are means 6 SEM (n = 5–10). In each row values without a common letter significantly differ, P,0.05; NS, non-significant. Gene expression shown relative to the
LFD control group set at 1.00. IR, Insulin receptor; GCCR, Glucorticoid receptor; TNF-a, Tumour necrosis factor alpha; POMC, Pro-opiomelancortin; NPY, Neuropeptide Y;
ObR, Leptin receptor; GHS-R, Growth hormone secretatgogue receptor; PPARc, peroxisome proliferator activated receptor gamma; CPT1c, carnitine palmitoyltransferase
1c; IRS-1, Insulin receptor substrate 1.
doi:10.1371/journal.pone.0088904.t004
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in TAG levels, which was accompanied by the suppression of
FABP1 mRNA expression, similar to previous findings [4,6,71,72].
In the epididymal adipose tissue, WPI prevented the HFD-
induced FASN gene expression, albeit a recent study reported that
WPI does not affect the weight of the epididymal tissue in HFD fed
mice, but instead causes a reduction in subcutaneous fat pad
weight [20]. These data suggest that WPI affects cellular activity in
the liver and in specific adipose tissue depots. While it has been
suggested that whey protein may facilitate enhanced postprandial
chylomicron clearance via an alteration in LPL expression/activity
[73,74], here we did not find a WPI specific effect on LPL
expression or plasma TAG levels, but we did observe that intake of
the highest P/C ratio (40%-WPI) led to an increase adipose tissue
LPL mRNA expression which was accompanied by significant
reduction in plasma TAG levels, and a complete reversal of genes
involved in lipid accumulation (PPARc), fatty acid transport
(FATP1), and lipolysis (b3-AR). Given that HF feeding/obesity
down-regulates b3-AR mRNA expression [75], our data suggests
an increased adipocyte lipolysis, and reduction in adipose TAG
storage in HFD-40%WPI fed mice. Yet the endogenous CPT1b-
associated b-oxidation pathway and the UCP-2-associated path-
way in epididymal adipose tissue seem to be unaffected (CTP1b) or
suppressed (UCP-2) by raising the P/C ratio. This data raises the
possibility that the free fatty acids generated from the potentially
increased availability of b3-AR in the adipose may have been re-
directed for utilisation by other physiological processes active in
HFD-40% group, possibly leading to the increased metabolic
activity (VO2) observed in the animals. It is also noteworthy that
WPI has been shown to increase faecal fat excretion compared to
casein [5], which may have also contributed to the decreased
plasma TAG and NEFA seen here with intake of the highest P/C
ratio diet (HFD-40%WPI).
Given the link between HFD-induced obesity, low-grade
inflammation and insulin resistance [76,77], one could argue that
the dramatic reduction in fat mass observed with the highest P/C
ratio may underlie the effects on inflammatory markers in the
adipose tissue (TNFa and CD68) and the hypothalamus (TNFa),
along with simultaneous changes in expression of genes involved in
insulin signalling (IR, IRS-1 and GLUT4 in the adipose, IRS-1 in
liver and IR in the hypothalamus), and the reduction in plasma
glucose in these mice. Improvements to insulin sensitivity with
WPI have been reported previously [9,78], but our data suggested
that only an increased P/C ratio in the HFD facilitated
improvements to insulin signalling pathway associated gene
expression, particularly in the adipose, in parallel with reduced
HOMA-IR values.
Composition of gut microbiota
While many of the effects described above may be due to direct
WPI or P/C ratio-host interactions, the effect of WPI and P/C
ratio on the composition of the gut microbiota may also play an
important role in adiposity and weight gain in these animals. Here,
high throughput sequencing based analyses of faecal microbial
populations revealed the clustering of the microbiota from animals
in receipt of 30 and 40% WPI diets away from those in receipt of
20% kJ WPI or HFD-casein diets. Tranberg et al [20] recently
suggested that the efficient absorption of dairy whey proteins in the
small intestine may explain the absence of changes in the faecal
microbiota. This may explain the clustering of the microbiota from
animals fed 20% WPI or HFD-casein diets in our study. However,
it is apparent that the high concentrations of WPI present in the 30
and 40% WPI diets employed in our study had a more profound
effect, possibly due to additional whey proteins finding their way to
the large intestine and/or the overall change in the P/C ratio in
the diet. Consumption of the 30 and 40% WPI diets did not result
in a shift in the microbiota toward that of the LFD animals and
thus the effects on weight gain are not simply due to an overall
Figure 5. Impact of whey protein isolate and protein to carbohydrate ratio on the gut microbiota composition. Principal Coordinate
analysis (PCoA) of unweighted Unifrac distances of the 16srRNA sequences, demonstrating where sequences cluster according to diet group. Data
were generated from analysis of faecal samples collected from mice on 10% kJ low fat diet (LFD, D) or 45% kJ high fat diet (HFD,¤) or a HFD with
20% kJ whey protein isolate (HFD-20% WPI, #), 30% kJ WPI (HFD-30% WPI, e) or 40% kJ WPI (HFD-40% WPI, N)(n = 10).
doi:10.1371/journal.pone.0088904.g005
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conversion to a LFD-like microbiota. Specific taxonomic changes
were also noted in response to the different diets. In all cases
dietary WPI resulted in significant increases in Lactobacillaceae/
Lactobacillus and decreases in Clostridiaceae/Clostridium. Increased
proportions of Lactobacillus have previously also been observed in a
study of individuals following a regime of calorie restriction and
exercise [79]. However, in contrast, increased proportions of
Lactobacillus have also been noted in HFD fed rats [80] and diet-
induced obese mice [81]. While specific species of Lactobacillus have
been associated with both lean and obese gut microbiota profiles
and also to play a role in obesity and immune response regulation
[82–84], due to the length of the 16S sequences generated and the
high degree of sequence homology, we cannot assess changes in
proportions of Lactobacillus at the species level. An increase in the
proportions of Bifidobacteriaceae/Bifidobacterium was also observed in
both the HFD-20% WPI and HFD-30% WPI compared to the
HFD group. This result, combined with the aforementioned
increases in Lactobacillaceae/Lactobacillus, mirror those reported by
Sprong et al who suggest that whey proteins act as grow factors for
certain species of bacteria by an amino acid composition mediated
mechanism [19]. This pattern did not extend to the HFD-40%
WPI group suggesting that, at these high protein levels, other
factors are at play. Our observations are also consistent with
previous findings that high proportions of the class Clostridiales are
associated with the gut microbiota of animals fed a HFD [85],
while fasting reduces the levels of Clostridium [86]. Notably,
Clostridiaceae can produce short chain fatty acids as a product of
their metabolism [87], which can play an important role in the
regulation of immune cells and has been associated with
inflammation and obesity [88]. These differences, as well as
others in the Proteobacteria Actinobacteria Deferribacteres (phylum),
Desulfovibrionaceae Deferribacteraceae Veillonellaceae (family), Desulfovibrio
and Mucispirillum taxa in the HFD-20% whey protein relative to
HFD controls (20% casein) are particularly notable as these reflect
changes resulting from the specific presence of whey proteins in
the diet, in place of casein, rather than changes in the P/C ratio.
Changes in relative proportions may be attributed to (a) the ability
of bacteria to utilise whey proteins as a growth medium, (b) the
anti-microbial activity of whey protein/peptide components, (c)
decreased competition as a result of the whey proteins/peptides
antimicrobial activity or (d) whey protein mediated changes in the
host. Ultimately, the question of cause versus effect remains
unanswered, and so while the changes to the microbiota observed
may contribute to the mechanisms involved in controlling weight
gain, further studies with, for example germ free animals, will be
required to determine this definitively.
WPI effects on energy balance from a whole animal
context
Focusing on the experimental data gathered between weeks 17–
21, during which we measured metabolic parameters, faecal
microbial population, body composition and tissue and plasma
level of energy balance related parameters, it is clear that WPI
intake increased energy intake associated with the HFD, without
altering energy expenditure, as measured by VO2 and locomotor
activity. However, the body composition and body weight in the
HFD-WPI group does not appear to reflect a positive energy
balance, as animals showed a trend towards a reduction in fat mass
and increased lean mass. It is noteworthy in this regards that WPI
has been shown to increase faecal fat excretion [5] and we also
observed some subtle changes in the gut microbiota at a
phylogenic level that are associated with non-obese states, raising
the possibility of a reduced intestinal TAG absorption in the HFD-
WPI groups with increased energy intake, leading to similar body
weight trajectories as HFD controls. Increasing the P/C ratio by
changing WPI from 30 to 40% did not alter energy intake but
significantly accentuated energy expenditure with a concurrent
dramatic change in physiology.
In summary, our results show that WPI specifically normalises
energy intake, increases lean mass and causes a trend towards a
reduction in fat mass associated with prolonged high fat feeding.
Raising the P/C ratio had no effect on energy intake but
augmented metabolic activity and beneficially altered gene
expression profiles for lipid metabolism, inflammation and insulin
signalling, particularly in the adipose tissue. High throughput
analysis of gut microbiota revealed distinct changes in microbial
populations with increased P/C ratio causing clustering of 30/
40% WPI groups together and distinct from those of HFD and
20% WPI groups, but with specific phylogenetic differences
existing between the latter groups. These data indicate that
changes to P/C ratio have a dramatic effect on energy balance and
the composition of gut microbiota distinct from that seen with
Table 5. Gut microbiota composition as % of reads in mice
fed a 45%kJ high fat diet (HFD) or HFD with 20%, 30% or 40%
kJ whey protein isolate (WPI) for 21 weeks1.
HFD 20% WPI 30% WPI 40% WPI
Phylum
Proteobacteria 0.36a 0.63b 0.34ab 0.32a
Actinobacteria 0.63a 1.82b 3.79b 0.36c
Deferribacteres 0.57a 1.61b 1.56ab 2.03b
Family
Desulfovibrionaceae 0.12a 0.31b 0.21ab 0.23ab
Rikenellaceae 6.71ab 7.54b 3.9a 6.4ab
Bacteroidaceae 0.44a 0.42a 0.16b 0.21b
Lactobacillaceae 0.21a 3.03b 4.6b 2.14b
Bifidobacteriaceae 0.43a 1.71b 3.66b 0.22c
Deferribacteraceae 0.57a 1.59b 1.32ab 2.03ab
Peptostreptococcaceae 0.62a 1.79a 1.54a 8.01b
Succinivibrionaceae 0.13a 0.15a 0b 0b
Clostridiaceae 1.31a 0b 0b 0b
Veillonellaceae 0.02a 0.12b 0a 0a
Genus
Anaerobiospirillum 0.13a 0.15a 0b 0b
Desulfovibrio 0.07a 0.22b 0.17ab 0.15ab
Alistipes 4.33ab 4.41a 2.24b 3.76ab
Rikenella 1.04ab 0.49b 0.68b 1.08b
Bacteroides 0.44a 0.4a 0.16b 0.21ab
Oscillibacter 0.24a 0.67ab 0.42ab 0.52b
Lactobacillus 0.2a 3.03b 4.6b 2.39b
Bifidobacterium 0.43a 1.71b 3.66b 0.22c
Mucispirillum 0.57a 1.61b 1.56ab 1.92ab
Coprococcus 0.11ab 0.23b 0.06a 0.06ab
Turicibacter 0.56a 0.35a 0.15ab 0b
Clostridium 1.3a 0b 0b 0b
Peptostreptococus 0.1a 0.14a 0.12a 0.78b
1Data are means 6 SEM (n = 10). Statistically significant differences generated
using the Kruskal-Wallis algorithm. In each row values without a common letter
significantly differ, P#0.05.
doi:10.1371/journal.pone.0088904.t005
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changes to protein source. Future studies should focus on
determining whether the effects demonstrated for highest P/C
ratio are specific to the WPI content, a consequence of
macronutrient change, or both.
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